This study demonstrates an effective, simple, and selective method for monitoring mesalazine in pharmaceutical formulations using liquid phase micro-extraction (LPME) and spectrophotometry. Combining LPME with spectrophotometry is an efficient method for analysing various compounds in different matrices. This method is based on extracting the ion-pair formed between the blue indophenol produced by the oxidative reaction of mesalazine and syringic acid in an alkaline medium and a quaternary ammonium salt into a micro-volume of organic solvent. The experimental parameters influencing LPME performance, such as the type and concentration of the quaternary ammonium ion salt and the type and volume of the extractant solvent, were optimised for optimal detection. The linear range and the limit of detection for measuring red species in pharmaceutical formulations were determined to be 0.005-0.080μg/mL-1 and 0.003μg/mL-1, respectively, with a relative standard deviation of 4-6%. The method had a preconcentration factor of 50 at 520nm, making it highly efficient and reliable for monitoring mesalazine in pharmaceutical formulations.